Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that manufactures and distributes medical devices for the treatment of patients with chronic diseases at home. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. It markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. It also offers Kylee, a free mobile application that helps patients learn about lymphedema.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.08% year-on-year.
Overvalued
The company’s latest PE is 31.95, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 24.21M shares, decreasing 9.57% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 158.76K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.22.